MA
IMA

MUFG Americas’s ImageneBio Inc IMA Stock Holding History

MUFG Americas’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38
Closed -$2K – 409
2022
Q3 		$2K Buy
+38
New +$2.2K ﹤0.01% 813

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MUFG Americas's IMA Position: Q4 2022 in Review

MUFG Americas sold out of ImageneBio Inc (IMA) in Q4 2022, closing a stake of 38 shares — an estimated $2K sold.

MUFG Americas first reported a position in IMA in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 33 funds tracked by Wall St. Rank hold IMA as of Q4 2022.

  • MUFG Americas reported no remaining ImageneBio Inc position as of Q4 2022 after selling out during the quarter.
  • MUFG Americas sold 38 ImageneBio Inc shares in Q4 2022, an estimated $2K.
  • MUFG Americas first reported a position in ImageneBio Inc in Q3 2022 and held it in 1 quarter.
  • MUFG Americas's ImageneBio Inc position peaked at $2K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.